TLR9 and hepatocellular carcinoma: Recently, a rapid accumulating evidence demonstrated that CpG-ODN have been developed to stimulate the innate immune response in various diseases through the pathogen-associated molecular pattern receptor 9 (TLR9) [8], which are mainly expressed on immune cell [9], are also widely expressed on various tumor cells, including human HCC cells [10].